Approve a new drug to treat ovarian cancer
The National Administration of Drugs, Food and Medical Technology (Anmat) approved the use of bevacizumab (Avastin ®) as first-line treatment of advanced ovarian cancer (including epithelial, the fallopian tube and primary peritoneal). Thus, the recognized laboratory antiangiogenic Roche adds a new indication for he already had in the colon, lung, breast, renal and glioblastoma.
Ovarian cancer is one of the most common female cancer. It is estimated that worldwide there are about 220,000 cases a year, is responsible for 140,000 deaths annually and has the highest mortality rate among all gynecologic cancers in developed countries.
According to local statistics, in Argentina is estimated that there are 9 cases of ovarian cancer per 100 thousand women (about 2000 cases per year). In relation to these figures, Dr. Liliana Zamora, medical oncologist at the Hospital Service Italian said: "Historically we handle the numbers of countries that have strict tumor registries. There is still much to be done in our country, but we have today with the National Cancer Institute that will soon fill this data reliably. Today there is still underreported because many cases go unreported. Therefore, the figure is approximate. "
The vast majority of ovarian tumors (over 90%) correspond to the call for epithelial ovarian cancer are caused by the uncontrolled growth of epithelial cells that form the surface of that body. Dr. Luis Fein, director of clinical research at the Institute of Oncology of Rosario explained that "Ovarian cancer occurs when cells in the ovary become abnormal and divide without control or order. Cancer cells can invade and destroy the tissue around them. They can also be separated from the tumor and spread to form new tumors in other parts of the body. " So far not many treatment options against the disease and the prognosis for patients used to be adverse: with traditional treatments-surgery plus chemotherapy, only 20% of patients diagnosed with ovarian cancer in advanced stages survive more than 5 years after detection. Added to this is that about 70% of cases are diagnosed in advanced stages. This is because as it is a disease which lacks a specific detection method and effective, and initially ambiguous symptoms are often confused with less serious pathologies, it is diagnosed when the tumor has already spread ( metastasized) to other parts of the body. That's why I mentioned to ovarian cancer as "a silent murderer". "Unfortunately in most cases are diagnosed late and this is because they could not encounter a effective method for the early diagnosis of this pathology. Early stages are rarely discovered early and often respond to a chance finding, "said Dr. Zamora. However, as noted vaginal touch "a practice that should be done in all gynecological controls". "While there is no early detection methods for ovarian cancer, vaginal examination is part of the periodic checkup every woman who performs gynecological checkup.
The pelvic exam can detect a pelvic mass and induce suspicion of pelvic mass or abnormal, "he explained. Since one of the main predictors of successful treatment is early diagnosis of the disease, much of the research in this cancer are focused on diagnostic methods. After ensuring that the ovary is a type of cancer of high impact in everyday life of women, Dr. Zamora said that "the diagnosis of any disease that involves extensive surgeries and treatments later systemic treatments such as chemotherapy ovarian cancer, involves a change in the life of the woman, who must rearrange their daily life after treatment to be met. His work, his aesthetic, his new body image, sexuality undergo changes, some temporary and others permanent inevitably change the everyday woman.
Being a therapy "directed", which is added to traditional treatment with carboplatin and paclitaxel, bevacizumab helps control the growth and proliferation of the tumor without significant side effects add to chemotherapy. In advanced stages of ovarian cancer, allows the patient live longer with a better quality of life.
@Lazada:
We hope the article Approve a new drug to treat ovarian cancer is useful for you. if you like the article Approve a new drug to treat ovarian cancer please share this article Approve a new drug to treat ovarian cancer to your friends.
Post a Comment